JP3670211B2 - Lotion preparation containing powder - Google Patents
Lotion preparation containing powder Download PDFInfo
- Publication number
- JP3670211B2 JP3670211B2 JP2000391722A JP2000391722A JP3670211B2 JP 3670211 B2 JP3670211 B2 JP 3670211B2 JP 2000391722 A JP2000391722 A JP 2000391722A JP 2000391722 A JP2000391722 A JP 2000391722A JP 3670211 B2 JP3670211 B2 JP 3670211B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- powder
- weight
- external preparation
- lotion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 45
- 239000000843 powder Substances 0.000 title claims description 35
- 239000006210 lotion Substances 0.000 title claims description 19
- 239000000344 soap Substances 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 17
- 239000000194 fatty acid Substances 0.000 claims description 17
- 229930195729 fatty acid Natural products 0.000 claims description 17
- 229910052751 metal Inorganic materials 0.000 claims description 16
- 239000002184 metal Substances 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 14
- 239000002537 cosmetic Substances 0.000 claims description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims description 7
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 claims description 3
- 229940063655 aluminum stearate Drugs 0.000 claims description 3
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 3
- -1 zinc and aluminum Chemical class 0.000 description 17
- 239000000203 mixture Substances 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical class CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical class CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000002628 heparin derivative Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229910001607 magnesium mineral Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008336 pharmaceutical lotion Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical group [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、皮膚外用剤に関し、更に詳細には、粉体を含有したローション剤形の皮膚外用剤に関する。
【0002】
【従来の技術】
粉体類は、ファンデーションなどに於いて皮膚トラブルを隠蔽したり、紫外線から肌を防護したり、光学効果により美しく装ったりする作用を有するため、化粧料に含有されることが多い。加えて、例えば酸化亜鉛のように抗炎症作用等の生理的作用を有するものもあることから、皮膚外用医薬にもままとして含有される。かかる粉体類の多くは金属酸化物であり、その比重は極めて高く、水系の製剤に含有させた場合には、沈降を起こし、粉体同士が分散媒を介して強く結合する、所謂ケーキング現象を起こすことが多々ある。これ故、水系の粉体含有製剤に於いては、粉体の再分散促進剤を配合したり、ステレスボールの様な攪拌子を入れたりして、再分散を高める手段が講じられている。かかる再分散促進剤としては、ポリ燐酸ナトリウムなどのような水溶性の燐酸塩が用いられている。しかしながら、粉体類の多くは等電点を有するが故に、ケーキングと再分散性に好適な塩の濃度は粉体によって異なり、燐酸塩の添加は一義的に再分散性を高めることにはつながらず、却って、ケーキングの際の粉体同士の結びつきを強固にすることすらあり解決手段とは言い難かったし、攪拌子は組成物中への金属イオンの溶出の危険をはらんでいる上、強固なケーキングを当初の状態にまで再分散させるほどの能力は期待できなかった。即ち、ローション製剤などの水系製剤形に於いて、ケーキングを起こさずに粉体を含有させる技術の開発が望まれていた。
【0003】
一方、粉体を含有するローション剤形の皮膚外用剤に於いて、脂肪酸金属石鹸を含有させた例は無いし、かかる脂肪酸金属石鹸を含有する、ローション剤形の皮膚外用剤に於いて、粉体を含有させた場合ケーキングが抑制されることも全く知られていない。
【0004】
【発明が解決しようとする課題】
本発明は、この様な状況下為されたものであり、ローション製剤などの水系製剤形に於いて、ケーキングを起こさずに粉体を含有させる技術を提供することを課題とする。
【0005】
【課題を解決するための手段】
本発明者らは、この様な状況に鑑みて、ローション製剤などの水系製剤形に於いて、ケーキングを起こさずに粉体を含有させる技術を求めて鋭意研究努力を重ねた結果、粉体を含有するローション剤形の皮膚外用剤に於いて、脂肪酸金属石鹸を含有させることにより、この様な技術が具現化できることを見出し発明を完成させるに至った。即ち、本発明は以下に示す技術に関するものである。
(1)粉体を含有するローション製剤の皮膚外用剤に於いて、脂肪酸金属石鹸を含有することを特徴とする、皮膚外用剤。
(2)脂肪酸金属石鹸が、ステアリン酸亜鉛、ステアリン酸アルミニウム及びステアリン酸マグネシウムから選ばれる1種乃至は2種以上であることを特徴とする、(1)に記載の皮膚外用剤。
(3)粉体のケーキングが抑制されていることを特徴とする、(1)又は(2)に記載の皮膚外用剤。
(4)化粧料であることを特徴とする、(1)〜(3)何れか1項に記載の皮膚外用剤。
以下、本発明について実施の形態を中心に詳細に説明を加える。
【0006】
【発明の実施の形態】
(1)本発明の皮膚外用剤の必須成分である脂肪酸金属石鹸
本発明の皮膚外用剤は、脂肪酸金属石鹸を含有することを特徴とする。本発明で言う脂肪酸金属石鹸とは、化粧料などで定義されている脂肪酸金属石鹸と同一のものであって、脂肪酸のカルボキシル基の水素原子が、アルカリ金属以外の金属、好適にはマグネシウム等のアルカリ土類金属、亜鉛やアルミニウムなどの両性金属に置換した形態の塩であり、特に好ましいものとしては、パルミチン酸、ステアリン酸、ベヘン酸とマグネシウム、亜鉛或いはアルミニウムとの塩が挙げられ、これらの内では、ステアリン酸マグネシウム、ステアリン酸亜鉛又はステアリン酸アルミニウムが特に好ましく例示できる。これら脂肪酸金属石鹸は唯1種を含有させることもできるし、2種以上を組み合わせて含有させることもできる。かかる脂肪酸金属石鹸は、沈降した粉体類が相互に強く結合する、所謂ケーキングの発生を抑制する作用に優れ、粉体が沈降した粉体含有化粧料を振とうする事により、沈降した粉体を容易に再分散できる。本発明の皮膚外用剤に於ける、かかる脂肪酸金属石鹸の好ましい含有量は、皮膚外用剤全量に対して、総量で0.01〜5重量%であり、更に好ましくは0.05〜1重量%が例示できる。これは、かかる脂肪酸金属石鹸が少なすぎるとケーキングを抑制できない場合があり、多すぎると脂肪酸金属石鹸が分離し見た目が汚くなる場合があるからである。
【0007】
(2)本発明の皮膚外用剤
本発明の皮膚外用剤は、上記必須成分である脂肪酸金属石鹸を含有し、ローション剤形であることを特徴とする。ここで、本発明で言うローション剤形とは、粘度が1000センチストークス以下の低粘度の組成物であって、その形態としては特に限定されず、乳化分散タイプ、可溶化分散タイプ、単純分散タイプなどが好ましく例示できる。又、本発明の皮膚外用剤の特徴が含有している粉体がケーキングを起こしにくいことであることから、粉体も必須の構成要素となる。本発明の皮膚外用剤で含有できる粉体としては、通常化粧料や皮膚外用医薬組成物で使用されるものであれば特段の限定はされず、例えば、二酸化チタン、酸化亜鉛、酸化鉄、シリカ等の金属酸化物、珪酸カルシウム、珪酸マグネシウム等の珪酸塩、タルク、カオリン、マイカ、セリサイト、チタンマイカなどの鉱物類などが好ましく、具体的に例示できる。これら以外にもローション剤の溶媒に殆ど溶けないような有機物も粉体として取り扱うことができる。勿論これら粉体はその表面に処理がされてあっても良い。本発明の皮膚外用剤に於ける、粉体の好ましい含有量は、皮膚外用剤全量に対して、0.01〜20重量%であり、更に好ましくは0.05〜5重量%である。本発明の皮膚外用剤に於いては、上記の成分以外に、通常皮膚外用剤で使用される任意の成分を含有することができる。この様な任意の成分としては、例えば、スクワラン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、ホホバ油、カルナウバワックス,オレイン酸オクチルドデシル等のエステル類、ジメチコンやフェメチコンなどのシリコーン類、オリーブ油、牛脂、椰子油等のトリグリセライド類、ステアリン酸、オレイン酸、リチノレイン酸等の脂肪酸、オレイルアルコール、ステアリルアルコール、オクチルドデカノール等の高級アルコール、スルホコハク酸エステルやポリオキシエチレンアルキル硫酸ナトリウム等のアニオン界面活性剤類、アルキルベタイン塩等の両性界面活性剤類、ジアルキルアンモニウム塩等のカチオン界面活性剤類、ソルビタン脂肪酸エステル、脂肪酸
モノグリセライド、これらのポリオキシエチレン付加物、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル等の非イオン界面活性剤類、ポリエチレングリコール、グリセリン、1,3−ブタンジオール等の多価アルコール類、エタノール、水性の増粘・ゲル化剤、酸化防止剤、紫外線吸収剤、色剤、防腐剤、ヒアルロン酸及びその塩、トレハロース及びその類縁体、コンドロイチン硫酸及びその塩、ヘパリン類似物質、糖鎖を側鎖に有する高分子又はコラーゲンの等保湿性有効成分を含有することができる。本発明の皮膚外用剤は、これらの成分を常法に従って処理することにより、製造することができる。ここで、本発明で言う皮膚外用剤とは、皮膚に外用で投与する形態の組成物の総称であり、例えば、化粧料、皮膚外用医薬、皮膚外用殺菌剤等が例示できる。これらの内では化粧料に適用するのが特に好ましい。これは、粉体の含有量が多いからである。
【0008】
【実施例】
以下に、実施例を挙げて本発明について更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。
【0009】
<実施例1〜5>
下記に示す処方に従って、本発明の皮膚外用剤である、ローション化粧料を作成した。即ち、ロの成分を0.9mm丸穴スクリーンを装着したパルベライザーで粉砕し、イの成分とともに攪拌して、2相タイプのローション化粧料を得た。このものを試験管に5cc取り、遠心分離器で1分間3000回転で5分遠心分離を行い、しかる後、試験管ミキサーにて30分間攪拌し、再分散しなかった部分の長さを測定した。同時に、本発明の実施例1のローション化粧料のステアリン酸マグネシウムを水に置換した対照例1、ポリ燐酸ナトリウムに置換した比較例1、ラウリン酸ナトリウムに置換した比較例2も作成し、同様に検討を行った。結果を表1に示す。これより、本発明の皮膚外用剤であるローション化粧料は、配合した粉体の再分散性に優れることが判る。
イ
エタノール 10 重量部
1,3−ブタンジオール 5 重量部
メチルパラベン 0.1重量部
ポリオキシエチレン硬化ヒマシ油 0.1重量部
水 83.8重量部
ロ
粉体* 0.9重量部
ステアリン酸マグネシウム 0.1重量部
*詳細は表1に記す。
【0010】
【表1】
【0011】
<実施例6〜9>
実施例1〜5と同様に、下記に処方を示す如く、脂肪酸金属石鹸の種類を変えて、本発明の効果を調べた。結果を表2に示す。これより、脂肪酸金属石鹸としてはステアリン酸の金属石鹸が好ましいことが判る。
イ
エタノール 10 重量部
1,3−ブタンジオール 5 重量部
メチルパラベン 0.1重量部
ポリオキシエチレン硬化ひまし油 0.1重量部
水 83.8重量部
ロ
タルク 0.9重量部
脂肪酸金属石鹸** 0.1重量部
**詳細は表2に記す。
【0012】
【表2】
【0013】
<実施例10>
上記実施例と同様に金属石鹸の量を変動させて検討を行った。結果を表3に示す。これより、本発明の皮膚外用剤に於いて、脂肪酸金属石鹸は0.1重量%を中心とした含有量が特に好ましいことが判る。
イ
エタノール 10 重量部
1,3−ブタンジオール 5 重量部
メチルパラベン 0.1重量部
ポリオキシエチレン硬化ひまし油 0.1重量部
水 83.8重量部
ロ
タルク 0.9重量部
ステアリン酸マグネシウム ***重量部
***詳細は表3に記す。
【0014】
【表3】
【0015】
<実施例12>
下記に示す処方に従って、本発明の皮膚外用剤である、抗炎症医薬ローション製剤を作成した。製造方法は上記化粧料の実施例と同様に行った。このものの粘度は400センチストークスであり、上記ケーキング試験による沈降の長さは5mmであった。
イ
エタノール 10 重量部
1,3−ブタンジオール 5 重量部
メチルパラベン 0.1重量部
ポリオキシエチレン硬化ひまし油 0.1重量部
ヘパリン類似物質 0.2重量部
水 83.6重量部
ロ
タルク 0.3重量部
酸化亜鉛 0.6重量部
ステアリン酸マグネシウム 0.1重量部
【0016】
【発明の効果】
本発明によれば、ローション製剤などの水系製剤形に於いて、ケーキングを起こさずに粉体を含有させる技術が提供できる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an external preparation for skin, and more particularly to an external preparation for skin in a lotion dosage form containing powder.
[0002]
[Prior art]
Powders are often contained in cosmetics because they have the action of concealing skin troubles in foundations and the like, protecting the skin from ultraviolet rays, and being beautifully worn by optical effects. In addition, since some of them have physiological effects such as anti-inflammatory effects such as zinc oxide, they are contained as they are in medicines for external use as a skin. Many of such powders are metal oxides, and their specific gravity is extremely high. When they are contained in an aqueous preparation, they cause sedimentation and the so-called caking phenomenon in which the powders are strongly bonded via a dispersion medium. Is often caused. Therefore, in water-based powder-containing preparations, means for increasing the redispersion by blending a powder redispersion accelerator or adding a stirrer such as a sterle ball is taken. As such a redispersion accelerator, a water-soluble phosphate such as sodium polyphosphate is used. However, since many powders have an isoelectric point, the salt concentration suitable for caking and redispersibility varies depending on the powder, and the addition of phosphate uniquely improves the redispersibility. On the other hand, it was difficult to say that it was a solution because there was even a strong bond between powders during caking, and the stirrer had a risk of elution of metal ions into the composition, The ability to redistribute strong caking to its original state could not be expected. That is, there has been a demand for the development of a technique for incorporating powder without causing caking in an aqueous preparation such as a lotion preparation.
[0003]
On the other hand, there is no example in which a fatty acid metal soap is contained in a lotion dosage form skin external preparation containing powder, and in a lotion dosage form skin external preparation containing such a fatty acid metal soap, It is not known at all that caking is suppressed when the body is contained.
[0004]
[Problems to be solved by the invention]
The present invention has been made under such circumstances, and an object of the present invention is to provide a technique for containing powder without causing caking in an aqueous preparation such as a lotion preparation.
[0005]
In order to solve the problems]
In view of such a situation, the present inventors have made intensive research efforts in search of a technique for incorporating powder without causing caking in an aqueous preparation such as a lotion preparation. It has been found that such a technique can be realized by including a fatty acid metal soap in the external preparation for skin containing a lotion dosage form, and has completed the invention. That is, the present invention relates to the following technique.
(1) In the skin external preparation of the lotion formulation containing powder, characterized in that it contains a fatty acid metal soaps, skin external preparation.
(2) fatty Sankin genus soap, characterized in that zinc stearate, the one to be selected from aluminum stearate and magnesium stearate is more, the skin external preparation as described in (1).
(3) The external preparation for skin according to (1) or (2), wherein caking of the powder is suppressed.
(4) The skin external preparation according to any one of (1) to (3), which is a cosmetic.
Hereinafter, the present invention will be described in detail with a focus on embodiments.
[0006]
DETAILED DESCRIPTION OF THE INVENTION
(1) skin external preparation of the fatty acid metal soaps present invention is an essential component of the skin external preparation of the present invention is characterized by containing a fatty acid metal soap. The fatty acid metal soap referred to in the present invention is the same as the fatty acid metal soap defined in cosmetics and the like, and the hydrogen atom of the carboxyl group of the fatty acid is a metal other than an alkali metal, preferably magnesium. Alkaline earth metals, salts in the form of substitution with amphoteric metals such as zinc and aluminum, particularly preferred are salts of palmitic acid, stearic acid, behenic acid and magnesium, zinc or aluminum, and these Of these, magnesium stearate, zinc stearate or aluminum stearate can be particularly preferably exemplified. It These fatty Sankin genera soaps may also be included only one, can be contained in combination of two or more. Such fat Sankin genus soaps, precipitated particulate materials are strongly coupled to each other, excellent effect of inhibiting the occurrence of so-called caking, by shaking the powder-containing cosmetic powder had settled, sedimented The powder can be easily redispersed. In the skin external preparation of the present invention, preferably the content of the fatty Sankin genus soaps, to the total amount of the skin treatment composition is 0.01 to 5 wt% in total, more preferably 0.05 to 1 The weight% can be exemplified. This may not be suppressed when such a fat Sankin genus soap is too small caking is because too much of fat Sankin genus soap might look separated it becomes dirty.
[0007]
(2) the external preparation for skin external preparation for skin of the Invention The present invention contain fat Sankin genus soaps are the essential components, characterized in that it is a lotion form. Here, the lotion dosage form referred to in the present invention is a low-viscosity composition having a viscosity of 1000 centistokes or less, and the form thereof is not particularly limited. Emulsified dispersion type, solubilized dispersion type, simple dispersion type Etc. can be preferably exemplified. In addition, since the powder containing the characteristics of the external preparation for skin of the present invention is less susceptible to caking, the powder is also an essential component. The powder that can be contained in the external preparation for skin according to the present invention is not particularly limited as long as it is usually used in cosmetics and external pharmaceutical compositions for skin. For example, titanium dioxide, zinc oxide, iron oxide, silica Metal oxides such as calcium silicate, silicates such as calcium silicate and magnesium silicate, and minerals such as talc, kaolin, mica, sericite, and titanium mica are preferable and can be specifically exemplified. In addition to these, organic substances that are hardly soluble in the solvent of the lotion agent can also be handled as powder. Of course, these powders may be each other is the processing on the front surface. The preferred content in, the powder in the skin external preparation of the present invention, with respect to the total amount of the skin treatment composition is 0.01 to 20 wt%, more preferably from 0.05 to 5% by weight. In the external preparation for skin of the present invention, in addition to the above-mentioned components, any components that are usually used in external preparations for skin can be contained. Examples of such optional components include hydrocarbons such as squalane, petrolatum, and microcrystalline wax, jojoba oil, carnauba wax, esters such as octyldodecyl oleate, silicones such as dimethicone and femethicone, olive oil, Triglycerides such as beef tallow and coconut oil, fatty acids such as stearic acid, oleic acid and lithinolic acid, higher alcohols such as oleyl alcohol, stearyl alcohol and octyldodecanol, anionic surface activity such as sulfosuccinic acid ester and sodium polyoxyethylene alkyl sulfate Agents, amphoteric surfactants such as alkylbetaine salts, cationic surfactants such as dialkylammonium salts, sorbitan fatty acid esters, fatty acid monoglycerides, polyoxyethylene adducts thereof, polymers Nonionic surfactants such as oxyethylene alkyl ethers and polyoxyethylene fatty acid esters, polyhydric alcohols such as polyethylene glycol, glycerin and 1,3-butanediol, ethanol, aqueous thickening and gelling agents, and antioxidants Moisturizing effect of chemicals, ultraviolet absorbers, colorants, preservatives, hyaluronic acid and its salts, trehalose and its analogs, chondroitin sulfate and its salts, heparin-like substances, polymers having sugar chains in the side chain or collagen Ingredients can be included. The external preparation for skin of the present invention can be produced by treating these components according to a conventional method. Here, the external preparation for skin referred to in the present invention is a general term for compositions in the form of external administration to the skin, and examples thereof include cosmetics, external preparations for skin, and antibacterial agents for external use. Of these, application to cosmetics is particularly preferred. This is because the powder content is large.
[0008]
【Example】
Hereinafter, the present invention will be described in more detail with reference to examples, but it goes without saying that the present invention is not limited to such examples.
[0009]
<Examples 1-5>
A lotion cosmetic, which is an external preparation for skin of the present invention, was prepared according to the formulation shown below. That is, the component (b) was pulverized with a pulverizer equipped with a 0.9 mm round hole screen and stirred with the component (a) to obtain a two-phase type lotion cosmetic. Take 5 cc of this in a test tube, centrifuge for 5 minutes at 3000 rpm for 1 minute, and then stir for 30 minutes in a test tube mixer to measure the length of the part that was not redispersed. . At the same time, Comparative Example 1 in which the magnesium stearate of the lotion cosmetic of Example 1 of the present invention was replaced with water, Comparative Example 1 in which sodium polyphosphate was replaced, and Comparative Example 2 in which sodium laurate was replaced were also prepared. Study was carried out. The results are shown in Table 1. From this, it can be seen that the lotion cosmetic which is an external preparation for skin of the present invention is excellent in the redispersibility of the blended powder.
Iethanol 10 parts by weight 1,3-butanediol 5 parts by weight methylparaben 0.1 part by weight polyoxyethylene hydrogenated castor oil 0.1 part by weight water 83.8 parts by weight B powder * 0.9 part by weight magnesium stearate 0 .1 part by weight * Details are given in Table 1.
[0010]
[Table 1]
[0011]
<Examples 6 to 9>
As in Example 1-5, as shown the formulation below, by changing the type of fat Sankin genus soaps, we examined the effect of the present invention. The results are shown in Table 2. From this, the fatty acid metal soaps seen that metal soaps stearic acid is preferred.
Lee ethanol 10 parts by weight 1,3-butanediol 5 parts by weight methyl paraben 0.1 part by weight of polyoxyethylene hydrogenated castor oil 0.1 parts by weight of water 83.8 parts by weight b Talc 0.9 parts by weight fatty Sankin genus soaps ** 0.1 parts by weight ** Details are given in Table 2.
[0012]
[Table 2]
[0013]
<Example 10>
As in the above example, the amount of metal soap was varied and examined. The results are shown in Table 3. From this, in the skin external preparation of the present invention, fatty Sankin genus soap it can be seen that particularly preferable content around 0.1 wt%.
(A) Ethanol 10 parts by weight 1,3-butanediol 5 parts by weight Methylparaben 0.1 part by weight Polyoxyethylene hydrogenated castor oil 0.1 part by weight Water 83.8 parts by weight Rotalc 0.9 part by weight Magnesium stearate *** weight Part
*** Details are given in Table 3 .
[0014]
[Table 3]
[0015]
<Example 12>
In accordance with the formulation shown below, an anti-inflammatory pharmaceutical lotion preparation, which is an external preparation for skin of the present invention, was prepared. The production method was the same as in the cosmetic examples. The viscosity of this product was 400 centistokes, and the length of sedimentation by the caking test was 5 mm.
Iethanol 10 parts by weight 1,3-butanediol 5 parts by weight methylparaben 0.1 part by weight polyoxyethylene hydrogenated castor oil 0.1 part by weight heparin-like substance 0.2 part by weight water 83.6 parts by weight rotalc 0.3 part by weight Zinc oxide 0.6 parts by weight Magnesium stearate 0.1 parts by weight
【The invention's effect】
ADVANTAGE OF THE INVENTION According to this invention, the technique which makes a powder contain without causing caking in aqueous | water-based formulation forms, such as a lotion formulation, can be provided.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000391722A JP3670211B2 (en) | 2000-12-25 | 2000-12-25 | Lotion preparation containing powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000391722A JP3670211B2 (en) | 2000-12-25 | 2000-12-25 | Lotion preparation containing powder |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002193739A JP2002193739A (en) | 2002-07-10 |
| JP2002193739A5 JP2002193739A5 (en) | 2004-12-09 |
| JP3670211B2 true JP3670211B2 (en) | 2005-07-13 |
Family
ID=18857821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000391722A Expired - Fee Related JP3670211B2 (en) | 2000-12-25 | 2000-12-25 | Lotion preparation containing powder |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3670211B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5622410B2 (en) * | 2010-03-12 | 2014-11-12 | 帝國製薬株式会社 | Ketoprofen-containing aqueous patch |
| CA2807115A1 (en) * | 2010-08-30 | 2012-03-08 | The Procter & Gamble Company | Opacifying lotion |
| JP6698387B2 (en) * | 2016-03-11 | 2020-05-27 | 小林製薬株式会社 | External composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2718638B1 (en) * | 1994-04-19 | 1996-05-24 | Oreal | Cosmetic filtering compositions containing an acid hydrophilic agent and use. |
| DE19824972A1 (en) * | 1998-06-04 | 1999-12-09 | Basf Ag | Use of cholesteric liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations |
| DE19848130A1 (en) * | 1998-10-19 | 2000-04-20 | Basf Ag | Cholesteric liquid crystalline polymer especially in pigment form, useful as UV filters in cosmetic and pharmaceutical preparations |
| JP4341871B2 (en) * | 2000-05-31 | 2009-10-14 | 信越化学工業株式会社 | Silicone polymer, silicone composition and cosmetic using the same |
| JP4920815B2 (en) * | 2000-06-01 | 2012-04-18 | 信越化学工業株式会社 | Cosmetics |
| JP2001354512A (en) * | 2000-06-13 | 2001-12-25 | Kanebo Ltd | Cosmetic |
| JP4723083B2 (en) * | 2000-12-08 | 2011-07-13 | 信越化学工業株式会社 | Method for producing silicone branched polyether-modified silicone compound and cosmetic containing compound obtained by this method |
| JP4949550B2 (en) * | 2000-12-11 | 2012-06-13 | 信越化学工業株式会社 | Cosmetics |
-
2000
- 2000-12-25 JP JP2000391722A patent/JP3670211B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002193739A (en) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101489701B1 (en) | Redispersible powder-dispersed cosmetic | |
| JP2007137879A (en) | Methods and compositions for hair removal | |
| JP3933805B2 (en) | Viscous or solid water cosmetic | |
| JP3857182B2 (en) | Skin cleansing composition | |
| JP2007119469A (en) | Methods and compositions for hair removal | |
| JP2025100777A (en) | Tranexamic acid combination preparation | |
| JP3670211B2 (en) | Lotion preparation containing powder | |
| WO2018043661A1 (en) | Agar film capsule | |
| JP2000026238A (en) | Jelly cleansing cosmetic | |
| JP3959205B2 (en) | Surface-treated powder and external preparation for skin containing the same | |
| JP3511415B2 (en) | Composite powder and cosmetics | |
| EA026743B1 (en) | Personal care compositions that include enrobed sugar | |
| JP2002193739A5 (en) | ||
| JP2003306410A (en) | Powder-containing water-in-oil emulsion cosmetic | |
| JP5133119B2 (en) | Cosmetic powder | |
| JP2008088147A (en) | Cosmetic | |
| JP3400213B2 (en) | Pack fee | |
| JP3563980B2 (en) | Skin cosmetics for wrinkle improvement | |
| JP2009263249A5 (en) | ||
| WO2020032006A1 (en) | Gel particles and external preparation for skin containing same | |
| JP2006022000A (en) | Oil-cleansing cosmetic | |
| JP3774180B2 (en) | Topical skin preparation | |
| JPH09194330A (en) | Oil-in-water-type solid cosmetic | |
| JP2001019619A (en) | Cosmetic for cleansing | |
| JP2004277364A (en) | Foam cleansing preparation for sensitive skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040907 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040914 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041111 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050405 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050413 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140422 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |
